We are live on ! Find out more
BIOL

Biolase, Inc.
BIOL

Delisted

BIOL was delisted on the 18th of June, 2024.

Back to rankings

18 hedge funds and large institutions have $116K invested in Biolase, Inc. in 2024 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

29% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 7

13% more funds holding

Funds holding: 16 → 18 (+2)

65% less capital invested

Capital invested by funds: $336K → $116K (-$219K)

Holders
18
Holders Change
+2
Holders Change %
+12.5%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
3
Reduced
2
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
+$64K
2
Millennium Management
Millennium Management
New York
+$56.9K
3
HF
HRT Financial
New York
+$49.3K
4
XT
XTX Topco
Cayman Islands
+$35.6K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$24.4K

Top Sellers

Rank Fund Capital Flow
1
AFM
Anson Funds Management
Texas
-$208K
2
ZF
Zhang Financial
Michigan
-$15.4K
3
Two Sigma Investments
Two Sigma Investments
New York
-$12K
4
BlackRock
BlackRock
New York
-$11.7K
5
UBS Group
UBS Group
Switzerland
-$6.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
VF
1
Virtu Financial
New York
$27K +$64K +131,248 +1,068%
Millennium Management
2
Millennium Management
New York
$22.1K +$56.9K +116,664 New
HF
3
HRT Financial
New York
$19K +$49.3K +101,143 New
XT
4
XTX Topco
Cayman Islands
$13.9K +$35.6K +73,079 New
Royal Bank of Canada
5
Royal Bank of Canada
Ontario, Canada
$9K +$24.4K +50,000 New
Citadel Advisors
6
Citadel Advisors
Florida
$7.56K +$12.7K +26,011 +188%
Susquehanna International Group
7
Susquehanna International Group
Pennsylvania
$6.96K +$17.9K +36,649 New
KWA
8
Kellett Wealth Advisors
Ohio
$3.62K – – –
Vanguard Group
9
Vanguard Group
Pennsylvania
$2.07K – – –
Bank of Montreal
10
Bank of Montreal
Ontario, Canada
$1.96K +$4.89K +10,040 New
Jane Street
11
Jane Street
New York
$1.92K +$4.93K +10,109 New
Qube Research & Technologies (QRT)
12
Qube Research & Technologies (QRT)
United Kingdom
$759 +$1.95K +4,000 New
BlackRock
13
BlackRock
New York
$191 -$11.7K -24,011 -96%
TRCT
14
Tower Research Capital (TRC)
New York
$38 -$1.09K -2,247 -92%
FDCDDQ
15
Federation des caisses Desjardins du Quebec
Quebec, Canada
$7 – – –
Wells Fargo
16
Wells Fargo
California
$5 +$4 +9 +50%
HNB
17
Huntington National Bank
Ohio
$1 – – –
Fidelity Investments
18
Fidelity Investments
Massachusetts
$1 +$2 +5 New
AFM
19
Anson Funds Management
Texas
– -$208K -185,127 Closed
ZF
20
Zhang Financial
Michigan
– -$15.4K -13,770 Closed
Two Sigma Investments
21
Two Sigma Investments
New York
– -$12K -10,726 Closed
UBS Group
22
UBS Group
Switzerland
– -$6.3K -5,615 Closed
Osaic Holdings
23
Osaic Holdings
Arizona
– -$56 -50 Closed
Morgan Stanley
24
Morgan Stanley
New York
– -$32 -28 Closed
Bank of America
25
Bank of America
North Carolina
– -$26 -23 Closed

BIOL Hedge Fund Activity: Q1 2024 in Review

18 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Biolase, Inc. (BIOL) for Q1 2024, worth a combined $116K — down 65% from $336K a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new BIOL positions and 7 closed out — a net gain of 2 holders — while 3 added to existing stakes and 2 trimmed.

The largest buyer was Virtu Financial, adding an estimated $64K. The largest seller was Anson Funds Management, exiting entirely with an estimated $208K sold.

  • 18 institutional investors held Biolase, Inc. (BIOL) as of Q1 2024, up from 16 in Q4 2023.
  • Funds reported $116K of Biolase, Inc. stock for Q1 2024, down 65% quarter-over-quarter.
  • 9 funds opened new Biolase, Inc. positions in Q1 2024 and 7 closed out, a net change of +2 holders.
  • The largest Biolase, Inc. buyer in Q1 2024 was Virtu Financial, an estimated $64K added.
  • The largest Biolase, Inc. seller in Q1 2024 was Anson Funds Management, an estimated $208K sold.

Based on aggregated 13F filings for Q1 2024.